Showing results (121-130 of 184) with videos related to
Sort By:
Pageof 19
The Journal of Clinical Investigation|November 1, 1989
Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic miceC L Arteaga, L J Kitten, E B Coronado, et al.Cancer Research|June 1, 1986
Prognostic implications of ploidy and proliferative activity in diffuse large cell lymphomasK D Bauer, D E Merkel, J N Winter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Combined versus sequential chemo-endocrine therapy in advanced prostate cancer: final results of a randomized Southwest Oncology Group studyC K Osborne, B Blumenstein, E D Crawford, et al.Cancer Research|September 1, 1997
Comparison of estrogen receptor DNA binding in untreated and acquired antiestrogen-resistant human breast tumorsS R Johnston, B Lu, M Dowsett, et al.Journal of Steroid Biochemistry|December 1, 1985
Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor statusS E Rivkin, W A Knight, R McDivitt, et al.Journal of the National Cancer Institute|August 19, 1999
Loss of heterozygosity at D14S62 and metastatic potential of breast cancerP O'Connell, K Fischbach, S Hilsenbeck, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Prediction of clinical outcome from primary tamoxifen by expression of biologic markers in breast cancer patientsJ Chang, T J Powles, D C Allred, et al.The American Journal of Pathology|October 1, 1995
Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancerJ J Isola, O P Kallioniemi, L W Chu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomyS G Diab, S G Hilsenbeck, C de Moor, et al.Cancer Research|March 31, 2001
Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibitionM T Hartsough, S E Clare, M Mair, et al.Pageof 19